Izotropic Corporation

Commercializing a Dedicated Breast CT Platform for the Earlier Detection, Diagnosis and Treatment of Breast Cancers

Recent News

  • Izotropic Reaches Q3 Milestones and Provides Engineering Update

    Vancouver, British Columbia--(Newsfile Corp. - October 13, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, provides updates on the following:Q3 Milestones achieved as scheduled, including 3D imaging reconstruction software implementation, mechanical and electrical design, and clinical study designIzoView engineering updateMeetings with Starfish Medical Izotropic announced today that it completed noteworthy Q3...

    2021-10-13 8:00 AM EDT
  • Izotropic unterzeichnet Vereinbarung mit der Johns Hopkins University School of Medicine zur Entwicklung von Algorithmen für maschinelles lernen für Izoview Breast-CT

    Vancouver, British Columbia--(Newsfile Corp. - Dienstag, 21. September 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen"), ein Unternehmen zur Vermarktung der speziellen Brust-CT-Bildgebungsplattform IzoView für eine genauere Brustkrebserkennung und -diagnose, gab heute bekannt, eine Vereinbarung mit der Johns Hopkins University School of Medicine (JHU) abgeschlossen zu haben. Entwickelt werden soll dabei Bildrekonstruktionssoftware (tiefe maschinelle Lernalgorithmen) zur weiteren Verbesserung der Bildverarbeitungsleistung für Brust-CT bei gleichzeitiger Minimierung des Rechenaufwands1.Die JHU gilt als weltweit führend in der Entwickl

    2021-09-21 3:52 PM EDT
  • Izotropic Signs Agreement with Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT

    Vancouver, British Columbia--(Newsfile Corp. - September 21, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a Company commercializing a dedicated breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today it has entered into an agreement with Johns Hopkins University School of Medicine (JHU) to develop image reconstruction software (deep machine learning algorithms) to further improve the image processing performance of Breast CT while minimizing computational burden1.JHU is recognized...

    2021-09-21 8:00 AM EDT
  • Izotropic Nominated for Best New Radiology Device Award

    Vancouver, British Columbia--(Newsfile Corp. - September 9, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today that it received a semifinalist nomination for AuntMinnie.com's 2021 award campaign to recognize the best and brightest in medical imaging.Auntminnie.com, a leading radiology news website, has recognized Izotropic's IzoView Breast CT System in the Best New Ra

    2021-09-09 8:00 AM EDT
  • Izotropic Receives Notice of Allowance for New 3D X-Ray Beam Filter Patent From USPTO

    Vancouver, British Columbia--(Newsfile Corp. - September 8, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today it has received a Notice of Allowance in response to a patent application from the United States Patent and Trademark Office (USPTO).The patent pertains to a specialized 3D x-ray filter, known as a 3D-Beam Modulation Filter, that is designed to...

    2021-09-08 8:00 AM EDT
  • Izotropic Engages Consultants for Investor Relations and Dedicated Social Media and Communications Services

    Vancouver, British Columbia--(Newsfile Corp. - September 7, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing a dedicated Breast CT (computed tomography) imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers, announced today that it has engaged Oak Hill Financial to provide financial marketing services and Mr. Tyler Muir of TMM Capital Advisory to provide social media and communications services.Oak Hill Financial is a leading Canadian marketing and distribution firm, focused on IIROC...

    2021-09-07 9:00 AM EDT
  • Izotropic ernennt medizintechnischen F&E-Experten zum Executive VP für Produkttechnik

    Vancouver, British Columbia--(Newsfile Corp. - Freitag, 2. Juli 2021) -  Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" oder das "Unternehmen") ein Unternehmen, das die echte 3D dedizierte Brust-Computertomographie (CT)-Bildgebungstechnologie "Izoview" zur diagnostischen Identifizierung von Brustkrebs vermarktet, verkündete heute die Ernennung von Dr. Younes Achkire als EVP für Produkttechnik. Er wird für das endgültige Design und die Herstellung von Izoview und zukünftigen Zubehörprodukten verantwortlich sein."Als CEO bemühe ich mich in jeder Hinsicht, einen sehr ehrgeizigen Pla

    2021-07-02 2:17 PM EDT
  • Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering

    Vancouver, British Columbia--(Newsfile Corp. - June 30, 2021) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") a Company commercializing "Izoview," a true 3D, dedicated Breast Computed Tomography (CT) imaging technology for the diagnostic identification of breast cancers, announced today that it has appointed Dr. Younes Achkire as EVP of Product Engineering, responsible for the final design and fabrication of Izoview and future accessory products."As CEO, I am committed on every level to execute a very aggressive...

    2021-06-30 8:00 AM EDT